Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

Artificial intelligence (AI)-based drug developer Isomorphic Labs said it has raised $600 million in its first external funding round, with the proceeds expected to accelerate its research and ...

The finding means that building larger AI models for protein design, and feeding them more data, will produce predictably ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict the shape of not only proteins but also DNA, RNA and other biological ...

AMPLY, the company behind the proprietary AMPLYfolioAI platform, is accelerating the discovery of new medicines for complex ...

Although still under refinement, ASERIA represents a significant step towards integrating AI more effectively into drug design. The final presentation of the session was left to Matt Armstrong ...

We may make money when you click on links to our partners. Learn More. AI drug design and development company Isomorphic Labs announced on Monday that it raised $600 million in its first external ...

Isomorphic Labs, a young company whose artificial intelligence technology for drug research has already landed partnerships with big pharmaceutical companies, unveiled $600 million in new ...

Drug discovery companies are already deploying advanced AI technologies and algorithms to boost drug research, design and testing and are using the technology to streamline supply chain operations ...

The funding will accelerate further development of Isomorphic’s AI drug design engine and support the company’s goal of bringing its discovered drugs to clinical trials. Isomorphic Labs was ...